0001209191-23-005067.txt : 20230126 0001209191-23-005067.hdr.sgml : 20230126 20230126164059 ACCESSION NUMBER: 0001209191-23-005067 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230124 FILED AS OF DATE: 20230126 DATE AS OF CHANGE: 20230126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERNSTEIN HOWARD PHD MD CENTRAL INDEX KEY: 0001262409 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39662 FILM NUMBER: 23558336 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SQZ Biotechnologies Co CENTRAL INDEX KEY: 0001604477 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462431115 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 ARSENAL YARDS BLVD., STE. 210 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-898-8824 MAIL ADDRESS: STREET 1: 200 ARSENAL YARDS BLVD., STE. 210 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-24 0 0001604477 SQZ Biotechnologies Co SQZ 0001262409 BERNSTEIN HOWARD PHD MD 200 ARSENAL YARDS BLVD, SUITE 210 WATERTOWN MA 02472 1 1 0 0 Interim Chief Executive Office Stock Option 0.73 2023-01-24 4 A 0 830000 0.00 A 2033-01-24 Common Stock 830000 830000 D The option vests and becomes exercisable as to 25% of the underlying securities on January 24, 2024 and in 36 substantially equal monthly installments thereafter, subject to limited acceleration upon involuntary termination. /s/ Lawrence Knopf, Attorney in Fact for Howard Bernstein 2023-01-26